INFLIXIMAB — all Canadian products
9 DINs
8 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is INFLIXIMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02496933 | AVSOLA | AMGEN CANADA INC | Powder For Solution | Intravenous | INFLIXIMAB 100 MG | Marketed | |
| 02523191 | IXIFI | PFIZER CANADA ULC | Powder For Solution | Intravenous | INFLIXIMAB 100 MG | Marketed | |
| 02510308 | OMVYENCE | JANSSEN INC | Powder For Solution | Intravenous | INFLIXIMAB 100 MG | Approved | |
| 02419475 | REMDANTRY | CELLTRION INC. | Powder For Solution | Intravenous | INFLIXIMAB 100 MG | Marketed | |
| 02244016 | REMICADE | JANSSEN INC | Powder For Solution | Intravenous | INFLIXIMAB 100 MG | Marketed | |
| 02511576 | REMSIMA SC | CELLTRION INC. | Kit; Solution | Subcutaneous | INFLIXIMAB 120 MG | Approved | |
| 02511584 | REMSIMA SC | CELLTRION INC. | Kit; Solution | Subcutaneous | INFLIXIMAB 120 MG | Marketed | |
| 02470373 | RENFLEXIS | SAMSUNG BIOEPIS CO., LTD | Powder For Solution | Intravenous | INFLIXIMAB 100 MG | Marketed | |
| 02419483 | REMSIMA | CELLTRION INC. | Powder For Solution | Intravenous | INFLIXIMAB 100 MG | Cancelled Post Market |
Browse other molecules: